Life Science Company News

Reset
Results 321 - 340 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16 17  18  19  20  21  22  23  24  25 »

Insilico Medicine Announces First-in-Human Study for Orally PHD Inhibitor ISM5411 for Inflammatory Bowel Disease (IBD)

Read more ››
By: PR Newswire Association LLC. - 04 Dec 2023
Related companies:  InSilico Medicine Inc.

VESTECK, invited to present at the 16th Annual Greenberg Stent Summit, Boston, MA

Read more ››
By: PR Newswire Association LLC. - 04 Dec 2023
Related companies:  VESTECK, Inc.

Crystal Pharmatech's CDMO Business Unit successfully passed the dual certification of GMP and GDP conducted by SGS

Read more ››
By: PR Newswire Association LLC. - 04 Dec 2023
Related companies:  Crystal Pharmatech Co., Ltd. (China)

CENTENE CEO SARAH M. LONDON NAMED ONE OF MODERN HEALTHCARE'S 100 MOST INFLUENTIAL PEOPLE

Read more ››
By: PR Newswire Association LLC. - 04 Dec 2023
Related companies:  Centene Corporation

Abbisko Therapeutics Announced the Entry into a Licensing Agreement for Pimicotinib (ABSK021) with Merck

Read more ››
By: PR Newswire Association LLC. - 04 Dec 2023
Related companies:  Abbisko Therapeutics Co., Ltd.

Technoderma Medicines Completes Phase 1 Dose Escalation Clinical Trial of TDM-180935 for Atopic Dermatitis

Read more ››
By: PR Newswire Association LLC. - 04 Dec 2023

CARsgen's CT071 Received IND Clearance from the FDA for Treating Relapsed/Refractory Multiple Myeloma or Relapsed/Refractory Primary Plasma Cell Leukemia

Read more ››
By: PR Newswire Association LLC. - 04 Dec 2023
Related companies:  CARsgen Therapeutics Holdings Limited

Pioneering health innovations at China Int'l Supply Chain Expo

Read more ››
By: PR Newswire Association LLC. - 04 Dec 2023

Powered by Its Industry-Leading Comprehensive Multi-Omic Database, Caris Life Sciences to Showcase Research at the 2023 San Antonio Breast Cancer Symposium

Read more ››
By: PR Newswire Association LLC. - 04 Dec 2023
Related companies:  Caris Life Sciences

Lilly Extends Tender Offer to Acquire POINT Biopharma to Dec. 15, 2023

Read more ››
By: PR Newswire Association LLC. - 04 Dec 2023
Related companies:  Eli Lilly and Company

Syndax to Host Investor Event to Discuss Axatilimab and Revumenib Data Updates at 65th ASH Annual Meeting

Read more ››
By: PR Newswire Association LLC. - 04 Dec 2023
Related companies:  Syndax Pharmaceuticals, Inc.

GOPIVOT™ CELEBRATES RENEWED PARTNERSHIP WITH C.A. SHORT COMPANY AND EMPHASIZES A FRESH FOCUS ON MENTAL HEALTH INITIATIVES IN 2024

Read more ››
By: PR Newswire Association LLC. - 04 Dec 2023

RedHill Announces New, Non-Dilutive External Funding of Entire RHB-107 COVID-19 300-Patient Phase 2 Study

Read more ››
By: PR Newswire Association LLC. - 04 Dec 2023

Sensorium Therapeutics Announces Appointment of Veteran Biotech Executive Alexandra Glucksmann, Ph.D., as CEO as the Company Progresses Toward the Clinic

Read more ››
By: PR Newswire Association LLC. - 04 Dec 2023
Related companies:  Sensorium Therapeutics

Nanoscope Therapeutics Continues Leadership Growth; Welcomes Accomplished Finance and Biotech Leader Glenn Sblendorio as Chairman of the Board

Read more ››
By: PR Newswire Association LLC. - 04 Dec 2023
Related companies:  Nanoscope Therapeutics, Inc

Stealth BioTherapeutics to Present at the Baird 2023 Biotech Discovery Series

Read more ››
By: PR Newswire Association LLC. - 04 Dec 2023
Related companies:  Stealth BioTherapeutics Inc.

Coeptis Therapeutics to Present at the Emerging Growth Conference

Read more ››
By: PR Newswire Association LLC. - 04 Dec 2023
Related companies:  Coeptis Therapeutics Inc

Cytonus Secures Series A Financing to Advance Pipeline of Novel Cargocyte™-based Medicines

Read more ››
By: PR Newswire Association LLC. - 04 Dec 2023
Related companies:  Cytonus Therapeutics Inc.

MIRA Pharmaceuticals Releases Breakthrough Data from Artificial Intelligence Simulations

Read more ››
By: PR Newswire Association LLC. - 04 Dec 2023
Related companies:  MIRA Pharmaceuticals, Inc.

Global Bio-India 2023 attracts global interest for India's $300 billion biotech potential from companies, academia, and start-ups

Read more ››
By: PR Newswire Association LLC. - 04 Dec 2023
Results 321 - 340 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16 17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Try for free »